Table of Contents

2019-2024 Global Anaesthetic Medicines Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anaesthetic Medicines Consumption 2014-2024
  • 2.1.2 Anaesthetic Medicines Consumption CAGR by Region
• 2.2 Anaesthetic Medicines Segment by Type
  • 2.2.1 Tetrazolium
  • 2.2.2 Ketamine
  • 2.2.3 Sodium Oxybate
  • 2.2.4 Other
• 2.3 Anaesthetic Medicines Consumption by Type
  • 2.3.1 Global Anaesthetic Medicines Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Anaesthetic Medicines Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Anaesthetic Medicines Sale Price by Type (2014-2019)
• 2.4 Anaesthetic Medicines Segment by Application
  • 2.4.1 Hospital Use
  • 2.4.2 Clinic Use
  • 2.4.3 Other
• 2.5 Anaesthetic Medicines Consumption by Application
  • 2.5.1 Global Anaesthetic Medicines Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Anaesthetic Medicines Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Anaesthetic Medicines Sale Price by Application (2014-2019)

3 Global Anaesthetic Medicines by Players

• 3.1 Global Anaesthetic Medicines Sales Market Share by Players
  • 3.1.1 Global Anaesthetic Medicines Sales by Players (2017-2019)
  • 3.1.2 Global Anaesthetic Medicines Sales Market Share by Players (2017-2019)
• 3.2 Global Anaesthetic Medicines Revenue Market Share by Players
  • 3.2.1 Global Anaesthetic Medicines Revenue by Players (2017-2019)
  • 3.2.2 Global Anaesthetic Medicines Revenue Market Share by Players (2017-2019)
• 3.3 Global Anaesthetic Medicines Sale Price by Players
• 3.4 Global Anaesthetic Medicines Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Anaesthetic Medicines Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Anaesthetic Medicines Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Anaesthetic Medicines by Regions

• 4.1 Anaesthetic Medicines by Regions
  • 4.1.1 Global Anaesthetic Medicines Consumption by Regions
  • 4.1.2 Global Anaesthetic Medicines Value by Regions
• 4.2 Americas Anaesthetic Medicines Consumption Growth
• 4.3 APAC Anaesthetic Medicines Consumption Growth
• 4.4 Europe Anaesthetic Medicines Consumption Growth
• 4.5 Middle East & Africa Anaesthetic Medicines Consumption Growth

5 Americas

• 5.1 Americas Anaesthetic Medicines Consumption by Countries
  • 5.1.1 Americas Anaesthetic Medicines Consumption by Countries (2014-2019)
  • 5.1.2 Americas Anaesthetic Medicines Value by Countries (2014-2019)
• 5.2 Americas Anaesthetic Medicines Consumption by Type
• 5.3 Americas Anaesthetic Medicines Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anaesthetic Medicines Consumption by Countries
  • 6.1.1 APAC Anaesthetic Medicines Consumption by Countries (2014-2019)
  • 6.1.2 APAC Anaesthetic Medicines Value by Countries (2014-2019)
• 6.2 APAC Anaesthetic Medicines Consumption by Type
• 6.3 APAC Anaesthetic Medicines Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anaesthetic Medicines by Countries
  • 7.1.1 Europe Anaesthetic Medicines Consumption by Countries (2014-2019)
  • 7.1.2 Europe Anaesthetic Medicines Value by Countries (2014-2019)
• 7.2 Europe Anaesthetic Medicines Consumption by Type
• 7.3 Europe Anaesthetic Medicines Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anaesthetic Medicines by Countries
  • 8.1.1 Middle East & Africa Anaesthetic Medicines Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Anaesthetic Medicines Value by Countries (2014-2019)
• 8.2 Middle East & Africa Anaesthetic Medicines Consumption by Type
• 8.3 Middle East & Africa Anaesthetic Medicines Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Anaesthetic Medicines Distributors
• 10.3 Anaesthetic Medicines Customer

11 Global Anaesthetic Medicines Market Forecast

• 11.1 Global Anaesthetic Medicines Consumption Forecast (2019-2024)
• 11.2 Global Anaesthetic Medicines Forecast by Regions
  • 11.2.1 Global Anaesthetic Medicines Forecast by Regions (2019-2024)
  • 11.2.2 Global Anaesthetic Medicines Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Anaesthetic Medicines Forecast by Type
• 11.8 Global Anaesthetic Medicines Forecast by Application

12 Key Players Analysis

• 12.1 AstraZeneca
  • 12.1.1 Company Details
  • 12.1.2 Anaesthetic Medicines Product Offered
  • 12.1.3 AstraZeneca Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 AstraZeneca News
• 12.2 Fresenius-Kabi
  • 12.2.1 Company Details
  • 12.2.2 Anaesthetic Medicines Product Offered
  • 12.2.3 Fresenius-Kabi Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Fresenius-Kabi News
• 12.3 BbVie Laboratories
  • 12.3.1 Company Details
  • 12.3.2 Anaesthetic Medicines Product Offered
  • 12.3.3 BbVie Laboratories Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 BbVie Laboratories News
• 12.4 Baxter Healthcare
  • 12.4.1 Company Details
  • 12.4.2 Anaesthetic Medicines Product Offered
  • 12.4.3 Baxter Healthcare Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Baxter Healthcare News
• 12.5 Braun
  • 12.5.1 Company Details
  • 12.5.2 Anaesthetic Medicines Product Offered
  • 12.5.3 Braun Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Braun News
• 12.6 Maruishi
  • 12.6.1 Company Details
  • 12.6.2 Anaesthetic Medicines Product Offered
  • 12.6.3 Maruishi Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Maruishi News
• 12.7 Piramal Healthcare
  • 12.7.1 Company Details
  • 12.7.2 Anaesthetic Medicines Product Offered
  • 12.7.3 Piramal Healthcare Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Piramal Healthcare News
• 12.8 Hikma Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Anaesthetic Medicines Product Offered
  • 12.8.3 Hikma Pharmaceuticals Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Hikma Pharmaceuticals News
• 12.9 Mylan
  • 12.9.1 Company Details
  • 12.9.2 Anaesthetic Medicines Product Offered
  • 12.9.3 Mylan Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Mylan News
• 12.10 Nhwa
  • 12.10.1 Company Details
  • 12.10.2 Anaesthetic Medicines Product Offered
  • 12.10.3 Nhwa Anaesthetic Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Nhwa News
• 12.11 Lunan
• 12.12 Hengrui

13 Research Findings and Conclusion

Anesthesia or anaesthesia is a state of controlled, temporary loss of sensation or awareness that is induced for medical purposes. It may include analgesia, paralysis, amnesia, or unconsciousness. A patient under the effects of anesthetic drugs is referred to as being anesthetized.

According to this study, over the next five years the Anaesthetic Medicines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anaesthetic Medicines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anaesthetic Medicines market by product type, application, key manufacturers and key regions and countries.

This study considers the Anaesthetic Medicines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tetrazolium
Ketamine
Sodium Oxybate
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Use
Clinic Use
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anaesthetic Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anaesthetic Medicines market by identifying its various subsegments.
Focuses on the key global Anaesthetic Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anaesthetic Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anaesthetic Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.